Navigation Links
Scioderm Initiates Phase 2B Study of SD-101, A Novel Topical Therapy, for Patients with Epidermolysis Bullosa
Date:1/6/2014

DURHAM, N.C., Jan. 6, 2014 /PRNewswire/ -- Scioderm, Inc. today announced the initiation of a Phase 2B study designed to evaluate the efficacy and safety of SD-101, a novel topical therapy, for the treatment of non-healing wounds in patients with Epidermolysis Bullosa (EB), a rare, genetic connective tissue disorder that typically manifests at birth or early childhood.

"People affected by EB suffer skin blisters, chronic wounds, almost constant pain and itching, and scarring," said Robert Ryan., Ph.D., President and Chief Executive Officer of Scioderm. "The current standard of care is palliative only and focuses primarily on daily wound care, bandaging and pain management. We believe SD-101 has the potential to initiate and continue healing of lesions in this patient population, and Scioderm is committed to develop SD-101 as expeditiously as possible as a treatment option for patients suffering from this devastating condition."

SD-101 for the treatment of EB has been granted an orphan drug designation in the US and in December 2013 received a positive opinion by the Committee for Orphan Medicinal Products (COMP) in the EU.  In addition, Scioderm was the first biotech to receive "Breakthrough Therapy" designation for SD-101 from the Food and Drug Administration (FDA) for the treatment of skin effects in patients with EB.  A breakthrough therapy designation conveys all of the fast track program features, as well as more intensive FDA guidance on an efficient drug development program. In addition, Scioderm was recently selected as  a 2013 "Fierce Top 15" company by FierceBiotech, considered as one of the top 15 emerging companies in the biotech industry. 

The Phase 2B study (SD-003) is a multi-site, prospective, randomized, placebo-controlled trial evaluating the efficacy and safety of SD-101 to close selected chronic cutaneous wounds and reduction in body surface area (
'/>"/>

SOURCE Scioderm, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Scioderm Announces Positive Phase II Data of Topical SD-101 on Wound Closure and Reduction of Lesions and Blisters in Children with Epidermolysis Bullosa (EB)
2. Scioderms Investigational New Drug (IND) Application for SD-101 for Treatment of Epidermolysis Bullosa (EB) Allowed by the FDA
3. Scioderms SD-101 Receives Breakthrough Therapy Designation from FDA for Treatment of Epidermolysis Bullosa
4. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
5. CSL Behring Initiates Study of Subcutaneous Administration of C1-esterase Inhibitor in Patients with Hereditary Angioedema
6. Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia
7. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
8. Oncos Therapeutics Initiates Phase I Clinical Study of CGTG-102, an Oncolytic Adenovirus for the Treatment of Solid Tumor Cancers
9. MAQUET Initiates Class I Recall of the FLOW-i Anesthesia System
10. Stryker Initiates Voluntary Product Recall of Modular-Neck Stems
11. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... 2015  BioElectronics Corporation (OTC Pink: BIEL), maker of ... Andrew J. Whelan , President will be interviewed ... Business" at 9am EDT on Wednesday, August 5 th ... http://tunein.com/radio/Money-Matters-Boston-1120-s27548/ Mr. ... the company,s flagship product, ActiPatch Therapy, is achieving in ...
(Date:8/3/2015)... Aug. 3, 2015  CytomX, a biopharmaceutical company ... today announced the promotion of several members of ... , who previously served as vice president of ... to senior vice president of corporate development and ... positions as the vice president of business development ...
(Date:8/3/2015)... , Aug. 3, 2015 Immune Pharmaceuticals, ... CEO, Dr. Daniel Teper , will present live ... August 6, 2015 TIME:   11:30AM EDT LINK:    ... live, interactive online event where investors are invited to ... the presentation hall as well as the association,s "virtual ...
Breaking Medicine Technology:UpTick News Wire Radio Show Will Interview BioElectronics' CEO Andrew Whelan 2CytomX Announces Management Team Promotions 2CytomX Announces Management Team Promotions 3Immune Pharmaceuticals to Webcast Live at VirtualInvestorConferences.com August 6 2
... Feb. 19, 2011 Genoptix, Inc. (Nasdaq: ... a memorandum of understanding ("MOU") providing for the settlement ... the Superior Court of the State of California, San ... Genoptix, Inc., Case No. 37-2011-00050762-CU-BT-NC, (2) Schwitters v. Genoptix, ...
... 18, 2011 TLC Vision announced today its plans for ... in San Diego.  Internationally recognized as leaders in field of ... Tanzer MD will lend their surgical skill and expertise to ... center will continue to be at the forefront of working ...
Cached Medicine Technology:Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 2Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 3Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 4Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 5Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 6Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 7Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 8Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 9Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 10Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 11TLC Vision Announces TLC Laser Eye Center San Diego 2
(Date:8/4/2015)... ... 04, 2015 , ... Mr Didier Cauchois, CIO of information ... , Mr Cauchois attributes the success to the dedication from the team ... healthcare technology offered by Winscribe's platform. , "We have already begun to ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... make the Isabel Symptom Checker available to all users of the KHIN personal ... check their symptoms in an easy, intuitive method, provides access to material on ...
(Date:8/3/2015)... ... August 04, 2015 , ... Approved provider of ... up of live courses for the month of August. , Physical therapy professionals ... or by purchasing a Physical Therapy Flex package. Flex packages allow therapists to ...
(Date:8/3/2015)... ... ... the most affordable web design and SEO services for start up companies. Every start ... Every company that is starting out needs to be online in this technology advanced ... start up need to be online, they need to physically be present and visible online. ...
(Date:8/3/2015)... , ... August 03, 2015 , ... sweetFrog Enterprises, LLC. ... location is the 20th sweetFrog store operating in the Lone Star State. The premium ... growing companies in 2014. , The store, located at 2916 US-75, Sherman, TX 38652, ...
Breaking Medicine News(10 mins):Health News:The Oscar Lambret Center (France) Completes First Stage Of Winscribe Text Rollout 2Health News:The Oscar Lambret Center (France) Completes First Stage Of Winscribe Text Rollout 3Health News:The Oscar Lambret Center (France) Completes First Stage Of Winscribe Text Rollout 4Health News:Isabel Healthcare Partners with the Kansas Health Information Network, Inc. to Deploy Isabel Symptom Checker within the MyKSHealth eRecord Personal Health Record 2Health News:Isabel Healthcare Partners with the Kansas Health Information Network, Inc. to Deploy Isabel Symptom Checker within the MyKSHealth eRecord Personal Health Record 3Health News:Elite Online CE Provider Announces Schedule of Live Courses For Florida Physical Therapy Continuing Education 2Health News:Elite Online CE Provider Announces Schedule of Live Courses For Florida Physical Therapy Continuing Education 3Health News:Web SEO Master, a division of SH Web Design & SH Web Commerce, Inc. begins offering Web Design and SEO Services for Start Up Companies located in Indianapolis, Indiana 2Health News:Web SEO Master, a division of SH Web Design & SH Web Commerce, Inc. begins offering Web Design and SEO Services for Start Up Companies located in Indianapolis, Indiana 3Health News:sweetFrog Reopens Texas Store Today 2
... CryoSat-2 Earth Explorer satellite has completed its journey to the ... for launch on 25 February. The satellite and support ... lorry on 12 January. The CryoSat mission is dedicated to ... ice floating in the polar oceans and variations in the ...
... could aid detection and diagnosis of major neurological diseases such ... according to new research by UCL scientists. The research, ... today in Cell Death & Disease , demonstrates a ... to be directly measured in real time. The method, demonstrated ...
... , , PARIS ... (AMP),has received a three-year grant of $4.9 million from ... prevention and control,in Africa . , ... core,members of the consortium, which will include several other leading health,organizations ...
... ... has acquired the assets of JDF Installation Logistics, one of the industry’s leading hospitality ... Kevin Hart and is headquartered in Chicago with strategic operations offices in Dallas and ... Chicago, ...
... ... stresses importance of greater awareness of brain injuries and serious lifelong implications for victims ... San Francisco, ... Year,s Day, in which top-ranked American snowboarder Kevin Pearce suffered a severe brain injury ...
... ... Wave of H1N1 Flu for Only $15 and No Waiting in Long Lines -- National ... ... operator of occupational health and urgent care centers in the nation, today announced that they ...
Cached Medicine News:Health News:ESA's ice mission arrives safely at launch site 2Health News:Seeing a diagnosis: How an eye test could aid Alzheimer's detection 2Health News:AMP Receives Grant From the Bill & Melinda Gates Foundation to Support Cholera Surveillance in Africa 2Health News:AMP Receives Grant From the Bill & Melinda Gates Foundation to Support Cholera Surveillance in Africa 3Health News:JK Logistical Operations Acquires JDL Installation Logistics 2Health News:Snowboarding Accident Provides Tragic Reminder of Serious Risk of Brain Injuries in Athletic and Occupational Environments 2Health News:U.S. HealthWorks in Spokane is Offering $15 H1N1 Vaccinations for Both Walk-Ins and On-Site 2
... device is a qualitative immunoassay ... inspect the,overdose usage of cocaine ... metabolite of,cocaine, in human urine ... 300 ng/mL. It is for ...
... test is an immunochromatography based one ... for qualitative determination of Benzodiazepines and ... a cut-off level of 300 ng/mL ... in the point of care location ...
... 2000, Applied Biosystems introduced the completely ... M 3100 Genetic Analyzer.,Now the innovative ... available in our new four-capillary ABI ... to-medium-throughput laboratory needs, the fully automated ...
... AcT diff2 delivers performance, ... office labs and smaller laboratories. ... that offers a small sample ... closed analysis modes, a wide ...
Medicine Products: